Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Database for New Dietary Ingredient Notifications Launches
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database for accessing all of the notifications that FDA has received since 1994 for new dietary ingredients (NDIs). The AHPA NDI Database launched on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period began.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Bi-national Food Agency Wants Comment on Proposed Changes to Regulations
Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food.
- Bi-national Food Agency Wants Comment on Proposed Changes to Regulations
Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food.
- FDA Acts to Seize Ephedra-Containing Dietary Supplements
The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon.
- FDA Acts to Seize Ephedra-Containing Dietary Supplements
The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1
The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)).
- Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1
The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)).
- FDA Acts to Protect Public from Fraudulent Avian Flu Therapies
Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza.
- FDA Acts to Protect Public from Fraudulent Avian Flu Therapies
Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- Canada- Recall of Chaparral-Containing Products
Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns.
- Canada- Recall of Chaparral-Containing Products
Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Direct Response Marketer Banned
A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements.
- Direct Response Marketer Banned
A. Glenn Braswell has been banned from the direct response marketing of foods, unapproved drugs, and dietary supplements.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- LycoRed Receives FDA Approval for Food Coloring
Company announces FDA approval for the use of Tomat-O-Red®, natural tomato lycopene, as a food coloring, to be used to color a variety of food and beverage products, including beverages, dairy products, confectionary products and baked goods.
- FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids
The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA.
- FDA Requests Seizure of More Dietary Supplements Containing Ephedrine Alkaloids
The U.S. Attorney's Office for the Western District of Pennsylvania has filed a Complaint for Forfeiture against Lipodrene, a dietary supplement that contains ephedrine alkaloids, seizing product valued at approximately $16,000 at ATF Fitness Products, Inc., in Oakmont, PA.
- FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients
FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury.
- FDA Warns Consumers about Brazilian Diet Pills Found to Contain Active Drug Ingredients
FDA is warning consumers not to use two unapproved drug products (Emagrece Sim Dietary Supplement, also known as the Brazilian Diet Pill and Herbathin Dietary Supplement) that are being marketed as dietary supplements for weight loss, as they may contain ingreidents, including controlled substances, that could lead to serious side effects or injury.
- NNFA Files Health Claims Comments
NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting.
- NNFA Files Health Claims Comments
NNFA recently submitted comments to the Food and Drug Administration (FDA) regarding health claims on product labels noting that manufacturers report that current FDA standards for health claim language is cumbersome and even conflicting.
- Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries
Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure.
- Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries
Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure.
- Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries
Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure.
- Navamedic Obtains Glucosamine HCl Product Approval in 19 European Countries
Navamedic's glucosamine HCl product has been approved in 19 countries for treatment of osteoarthritis of the knee. The product was approved in Sweden in August 2005, and has now been reviewed in the European Mutual Recognition Procedure.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Laval Quebec CANADA, December 9, 2005 – Neptune Technologies and Bioressources (NTB: TSXV), active in the field of high value-added natural product extraction from marine biomass, such as krill, is pleased to announce its strategic alliance with Degussa AG.
Degussa AG, the German giant and world’s largest manufacturer of specialty chemicals, is now a premier partner in Neptune’s long-term strategy for R&D and business development. The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG renowned expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids. Degussa AG will utilize its knowledge, expertise and high end technologies especially in the field of supercritical extraction know-how, in order for Neptune to accelerate its penetration and to rapidly grow with NKO™ as a functional food ingredient, ingeniously adapted to respond to the new requirements of the dairy and beverage markets, the largest and fastest growing segments of the 66.6B US$ functional food industry.
Concurrently Degussa AG and Neptune will join resources to exploit Neptune’s proprietary phospholipids and specifically 3 unique phospholipids known as; PhosphatidylCholine (PC), PhosphatidylEthanolamine (PE) and PhosphatidylInositol (PI), recognized as novel, because they are the only phospholipid carriers of EPA and DHA, omega-3 fatty acids and antioxidants known to science and industry, until today. Among others, this unique feature makes Neptune phospholipids highly stable and effective, characteristics that are considered essential for the use of phospholipids in the nutraceutical, pharmaceutical and nutrigenomic industries.
“In line with our mission and business plan, the Degussa AG alliance represents a timely and strategic partnership and it is a significant leap forward for Neptune,” said Mr. Henri Harland, the President and CEO of Neptune Technologies & Bioressources Inc.
About Neptune Technologies & Bioressources Inc. http://www.neptunebiotech.com Neptune Technologies & Bioressources Inc. develops high value added nutritional products from under exploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract™). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts. Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.
About Degussa AG http://www.degussa.com Degussa AG is the global market leader in specialty chemicals. Our innovative products and system solutions make an indispensable contribution to our customers' success, which we sum up by our claim "creating essentials". In fiscal 2004 Degussa's 45,000 employees worldwide generated sales of 11.2 billion euros and operating profits (EBIT) of 965 million euros.
Forward Looking Statements: Except for statements of historical fact, all statements in this news release - including, without limitation, statements regarding forecasts, plans and objectives of Neptune Technologies & Bioressources Inc. - are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate; actual results and future events could differ materially from those anticipated in such statements.
The stock Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this news release. |